Updates
-
The U.S. Food and Drug Administration (FDA) has approved Foundation Medicine’s FoundationOne CDx as a companion diagnostic test for identifying advanced breast cancer patients ... Read more
-
HHS Grant to Advance Breast Cancer Screenings Based on Ultrasound
A U.S. Department of Health and Human Services grant will fund research at two universities into whether an ultrasound technology might be more effective than ... Read more -
CHMP Favors Kadcyla Approval in EU for Certain HER2-positive Early Breast Cancer Patients
The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines Agency, has recommended that Kadcyla (ado-trastuzumab emtansine) be approved as ... Read more -
More Than $850M Raised for Inflammatory Breast Cancer Research
Susan G. Komen, the Inflammatory Breast Cancer (IBC) Research Foundation, and the Milburn Foundation have joined to raise more than $850,000 for research ... Read more
-
Fertility Clinics and Breast Cancer ‘Previvor’ Team Up to Raise Awareness About Genetic Risk of Disease
For patients with gene mutations that increase their risk for diseases such as breast ... -
Blood Test May Identify Breast Cancer Years Before Symptoms Appear, Pilot Study Suggests
A simple blood test – which measures antibodies against certain tumor proteins, or antigens ... -
Most Breast Cancers Found by Hand, MammaCare Researchers Say
Decades after establishing the recognized standard for performing and teaching clinical and personal breast ... -
First Patient Dosed in Phase 3 Trial of Tucatinib-Kadcyla Combo for Advanced HER2-Positive Breast Cancer
A Phase 3 trial exploring a combination of Seattle Genetics‘ tucatinib plus standard Kadcyla ... -
Hormone Therapy Has More Long-term Impact on Quality of Life Than Chemo, Study Suggests
Challenging conventional wisdom, new findings suggest that hormone therapy may have a greater impact ... -
Pathologist Creates Program Allowing Patients to Face Their Cancer Head-on
Massachusetts pathologist Lija Joseph, MD, has created an innovative program that allows patients, including ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
Clinical Trial of Tamoxifen-based Gel in Reducing Breast Density Recruiting in US, EU
News
The ability of a gel containing a tamoxifen-byproduct to reduce breast density — associated with an increased risk of breast cancer — is now being evaluated in a recruiting Phase 3 clinical trial. Approximately half of women in ... Read more